• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.

作者信息

Batinac Tanja, Hadzisejdić Ita, Brumini Gordana, Ruzić Alen, Vojniković Bozidar, Zamolo Gordana

机构信息

Department of Dermatovenerology, Rijeka University Hospital, Rijeka, Croatia.

出版信息

Coll Antropol. 2007 Jan;31 Suppl 1:17-22.

PMID:17469743
Abstract

To gain insight into the role and association of cell cycle and apoptosis regulatory proteins and telomerase activity in the course of progression of melanocitic lesions we have examined immunohistochemicaly, expression and the distribution of p53, bcl-2, Ki-67 and telomerase in 25 samples of common and dysplastic nevi, and 45 samples of primary invasive melanomas. Protein p53 expression was significantly increased in dysplastic as compared with common nevi and melanomas (p < 0.001). Bcl-2 protein expression was significantly increased in melanomas as compared with common aquired and dysplastic nevi (p = 0.001). Nevi and melanomas exhibited clear-cut differences in terms of Ki-67 expression. Telomerase expression was significantly increased in melanomas as compared with common acquired (p = 0.014) and dysplastic nevi (p < 0.001). Enhanced telomerase activity in association with increased bcl-2 expression in the course of melanoma progression could contribute to development and progression of melanoma.

摘要

相似文献

1
Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
Coll Antropol. 2007 Jan;31 Suppl 1:17-22.
2
Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.微小染色体维持蛋白在良性痣、发育异常痣、黑色素瘤及皮肤黑色素瘤转移灶中的表达
J Am Acad Dermatol. 2008 May;58(5):750-4. doi: 10.1016/j.jaad.2007.12.026. Epub 2008 Feb 4.
3
Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.髓样白血病-1在良性和恶性黑素细胞性病变中的表达
Oncol Rep. 2008 Apr;19(4):933-7.
4
Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.Spitz痣中的细胞周期和凋亡调节因子:与黑色素瘤和普通痣的比较。
J Am Acad Dermatol. 2007 May;56(5):815-24. doi: 10.1016/j.jaad.2006.09.015.
5
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.皮肤黑色素瘤中Bcl-2蛋白调控的免疫组织化学分析
Am J Pathol. 1995 Mar;146(3):643-50.
6
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.黑素细胞性病变中的hTERT表达:对石蜡包埋组织的免疫组织化学研究
J Cutan Pathol. 2005 Nov;32(10):680-4. doi: 10.1111/j.0303-6987.2005.00403.x.
7
Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.细胞周期和凋亡调节蛋白在角化棘皮瘤和鳞状细胞癌中的表达
Pathol Res Pract. 2006;202(8):599-607. doi: 10.1016/j.prp.2006.04.004. Epub 2006 Jun 15.
8
Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions.与其他痣细胞性病变相比,微小偏离型黑色素瘤中Ki-67和p53的表达情况。
Mod Pathol. 2003 Jun;16(6):525-9. doi: 10.1097/01.MP.0000072747.08404.38.
9
p53 Protein expression in nevi and melanomas.痣和黑色素瘤中的p53蛋白表达。
Arch Dermatol. 1993 Jun;129(6):739-43.
10
Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas.用于区分Spitz痣与恶性黑色素瘤的免疫组织化学标志物。
Mod Pathol. 1997 Sep;10(9):917-20.

引用本文的文献

1
Expression of Bcl-2, Melan A and HMB-45 in Dysplastic Nevi.Bcl-2、Melan A和HMB-45在发育异常痣中的表达。
Maedica (Bucur). 2016 Mar;11(1):38-43.
2
Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression.黑色素瘤中的生殖细胞蛋白:预后、诊断、治疗及表达理论
J Skin Cancer. 2012;2012:621968. doi: 10.1155/2012/621968. Epub 2012 Nov 12.
3
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.发育不良性痣:从历史视角到现代时代的管理:第二部分。分子方面和临床管理。
J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12; quiz 31-2. doi: 10.1016/j.jaad.2012.03.013.
4
Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.生物标志物:有用与不太有用——评估皮肤黑色素瘤的分子预后标志物。
J Invest Dermatol. 2010 Aug;130(8):1971-87. doi: 10.1038/jid.2010.149. Epub 2010 Jun 17.